COVID-19 Vaccine Recommendations Changes

This is a news story, published by USA Today, that relates primarily to Moderna news.

Moderna news

For more Moderna news, you can click here:

more Moderna news

News about vaccine development

For more vaccine development news, you can click here:

more vaccine development news

USA Today news

For more news from USA Today, you can click here:

more news from USA Today

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about

vaccinated adults

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest vaccinated males ages news, vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

vaccine availability

USA Today

•

Health

Changes are happening around COVID-19 vaccines: Here's what to know

Summary

Nutrition label

89% Informative

FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 boosters for healthy individuals under the age of 65 .

With this move, the FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

Other changes include the FDA 's request that both Pfizer and Moderna update their labels with a warning about the potential for vaccinated males ages 16 to 25 to develop inflammation of the heart muscle or other conditions.

Moderna ’s Spikevax was approved in late January 2022 .

Myocarditis is inflammation of the heart muscle and can reduce the heart's ability to pump blood.

Researchers looked at commercial health insurance claims data from inpatient and outpatient facilities.

The FDA noted that Moderna should replace the current label with one that reads “following administration of the 2023-2024 Formula of mRNA COVID-19 vaccines.

VR Score

Informative language

Neutral language

Article tone

formal

Language

English

Language complexity

Offensive language

not offensive

Hate speech

not hateful